Purchase Order 75N98026P01422

<p>The National Human Genome Research Institute issued a purchase order to Norgen Biotek Corp for $5,449.24, awarded June 20, 2017, with completion by June 30, 2017. No set-aside was used. Work is performed at the awardee's facility in Bethesda, Maryland. The order procures specialized molecular biology services, specifically exosomal RNA extraction, isolation, purification, and characterization in support of federal biomedical research initiatives.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for...

This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...

The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $156,600 firm fixed-price purchase order to Norgen Biotek Corp for small RNA characterization of urinary exosomes. This is a new purchase order with no set-aside designation, making it open to competition among all qualified contractors. Work will be performed at Norgen Biotek's facilities in Bethesda, Maryland, with an ultimate completion...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute (NHGRI) awarded a firm-fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services for future RNA sequencing. The potential value of the contract is $165,000.00, and the period of performance is from the award date of June 25, 2019, to the completion date of June 24, 2021. Norgen Biotek Corp has previously provided...

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $16,821.83 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosomal RNA purification services. This order, which does not have a set-aside designation, supports unspecified NIDDK and National Heart, Lung and Blood Institute clinical trials, as well as future RNA sequencing work for the National Human Genome Research Institute (NHGRI). Norgen Biotek...

<p>The National Human Genome Research Institute awarded a purchase order to DNA Genotek Inc. valued at $4,973.50 on June 28, 2018, for DNA collection and analysis products. Place of performance is Ottawa, Ontario, Canada. The order carried a firm fixed price and completed on July 27, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to DNA Genotek Inc. valued at $24,159.00 on May 23, 2018. Work is performed in Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of June 29, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to DNA Genotek Inc. valued at $8,310.00 on December 23, 2015, for DNA collection and analysis products, with final completion on December 21, 2020. Work is performed at DNA Genotek's facility in Ottawa, Ontario, Canada. The order carries firm fixed-price pricing and was issued through full and open competition with no set-aside.</p>